期刊文献+

HPLC-MS法测定人血浆中克拉霉素 被引量:6

HPLC-MS determination of clarithromycin in the human plasma
下载PDF
导出
摘要 目的建立HPLC-MS测定人血浆中克拉霉素的方法,并用于药物动力学研究。方法采用Thermo C18柱(150mm×2.1mm,5μm),柱温45℃,流动相为乙腈-15mmol·L^-1醋酸铵水溶液(含0.5%甲酸,0.1%三氟乙酸)(42:58),流速0.35mL·min^-1;以罗红霉素为内标,采用电喷雾电离正源,选择性离子方式检测。克拉霉素及内标用于定量分析的离子分别为m/z 748.6、m/z 837.8。血浆样品用甲醇沉淀蛋白后进样。结果克拉霉素在12.1~3400.0ng·mL^-1线性关系良好,相关系数为0.9999,最低检测限为2.0ng·mL^-1.萃取回收率〉83.0%,方法回收率103.7%~106.7%,日内日间精密度均〈7.9%。结论该方法结果准确、灵敏度高,适用于克拉霉素药物动力学和生物等效性研究。 Objective To establish an HPLC-MS method for the and to study the pharmacokinetics of clarithromycin. Methods determination of clarithromycin in the human plasma The analytes were determined by HPLC-MS method using Thermo C18 column (150 mm× 2.1 mm, 5 μm), acetonitrile-15 mmol · L^-1 ammonium acetate solution with 0.5% formic acid and 0.1% trifluoroacetic acid ( 42 : 58) as the mobile phase at 0.35 mL · min^-1 , with positive ion SIM detection of clarithromycin (m/z=748.6), using roxithromycin (m/z=837.8) the internal standard. The column temperature was 45℃. The plasma was deposited by methanol directly. Results The calibration curve was linear within 12.1-3 400.0 ng · mL^-1 (r =0. 999 9). The limit of quantitation was 2. 0 ng · mL^-1. The extraction recovery was 〉83.0% and the method recovery was 103.7%-106.7%. The relative standard deviations for the intra-day and inter-day were 〈7.9%. Conclusion The method is simple, accurate, fast and sensitive and suitable for the pharmacokinetics and bioequivalence study of clarithromycin.
出处 《中南药学》 CAS 2007年第2期111-113,共3页 Central South Pharmacy
关键词 克拉霉素 HPLC-MS 药物动力学 clarithromycin HPLC-MS bioequiavailability
  • 相关文献

参考文献8

二级参考文献18

  • 1黄圣凯,韩可勤.生物等效性评价的几种统计方法[J].中国临床药理学杂志,1993,9(1):43-46. 被引量:125
  • 2[3]Lohitnavy O,Lohitnavy M,Sareekan K,et al.Average bioequivalence of generic clarithromycin tablets in healthy Thai male volunteers[J].Biopharm Drug Dispos,2003,24(6):229
  • 3[4]Lohitnavy M,Lohitnavy O,Wittaya-areekul S,et al.Average bioequivalence of clarithromycin immediate released tablet formulations in healthy male volunteers[J].Drug Dev Ind Pharm,2003,29(6):653
  • 4[5]Martin SJ,Garvin CG,McBurney CR,et al.The activity of 14-hydroxy clarithromycin,alone and in combination with clarithromycin,against penicillin-and erythromycin-resistant Stre-ptococcus pneumoniae[J].J Antimicrob Chemother,2001,47(5):581
  • 5宋学勤,国外医药.抗生素分册,1997年,18卷,2期,119页
  • 6中华人民共和国药典委员会,中国药典.2,1995年,附录66页
  • 7J I D Wibawa, P N Shaw, D A Barrett. Quantification of clarithromycin,its 14 -hydroxy and decladinose metabolites in rat plasma, gastric juice and gastric tissue using high - performance liquid chromatography with electrochemical detection. J Chromatogr B,783 ( 2003 ) : 359.
  • 8J Sastre Torano, H - J Guehelaar *. Quantitative determination of the macrolide antibioticserythromycin, roxithromycin, azithromycin and clarithromycin inhuman serum by high - performance liquid chromatography using pre - column derivatization with 9 - fuorenylmethyloxycarbonyl chloride and fuorescence detection. J Chromatogr B, 720( 1998 ) :89.
  • 9宋学勤,吴星华.新型14元~16元大环内酯类抗生素的半合成[J].国外医药(抗生素分册),1997,18(2):119-124. 被引量:3
  • 10李焕德,张毕奎,阎小华,彭文兴.克拉霉素片人体药动学及相对生物利用度研究[J].中国药学杂志,1998,33(7):418-421. 被引量:9

共引文献31

同被引文献30

引证文献6

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部